Literature DB >> 32663318

Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.

Wanqing Chen1, He Li1, Jiansong Ren1, Rongshou Zheng1, Jufang Shi1, Jiang Li1, Maomao Cao1, Dianqin Sun1, Siyi He1, Xibin Sun2, Xiaoqin Cao2, Shixian Feng3, Jinyi Zhou4, Pengfei Luo4, Zhenqiu Zha5, Shangchun Jia5, Jialin Wang6, Hengmin Ma6, Hongmei Zeng1, Karen Canfell7, Jie He8.   

Abstract

The mortality benefit of esophageal squamous cell carcinoma (ESCC) screening has been reported in several studies; however, the results of ESCC screening programs in China are suboptimal. Our study aimed to develop an ESCC risk prediction model to identify high-risk individuals for population-based esophageal cancer screening. In total, 86 745 participants enrolled in a population-based esophageal cancer screening program in rural China between 2007 and 2012 were included in the present study and followed up until December 31, 2015. Models for identifying individuals at risk of ESCC within 3 years were created using logistic regressions. The area under the receiver operating curve (AUC) was determined to estimate the model's overall performance. A total of 298 individuals were diagnosed with ESCC within 3 years after baseline. The model of ESCC included the predictors of age, sex, family history of upper gastrointestinal cancer, smoking status, alarming symptoms of retrosternal pain, back pain or neck pain, consumption of salted food and fresh fruits and disease history of peptic ulcer or esophagitis (AUC of 0.81; 95% confidence interval: 0.78-0.83). Compared to the current prescreening strategy in our program, the cut-off value of 10 in the score-based model could result in 3.11% fewer individuals subjected to endoscopies and present higher sensitivity, slightly higher specificity and lower number needed to screen. This score-based risk prediction model of ESCC based on eight epidemiological risk factors could increase the efficiency of the esophageal cancer screening program in rural China.
© 2020 Union for International Cancer Control.

Entities:  

Keywords:  China; endoscopic screening; esophageal squamous cell carcinoma; individualized assessment; risk prediction

Year:  2020        PMID: 32663318     DOI: 10.1002/ijc.33208

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Huandi Zhou; Guohui Wang; Zhiqing Xiao; Yu Yang; Zhesen Tian; Chen Gao; Xuetao Han; Wei Sun; Liubing Hou; Junling Liu; Xiaoying Xue
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

2.  Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study.

Authors:  Junming Han; Lijie Wang; Huan Zhang; Siqi Ma; Yan Li; Zhongli Wang; Gaopei Zhu; Deli Zhao; Jialin Wang; Fuzhong Xue
Journal:  Front Oncol       Date:  2021-08-30       Impact factor: 6.244

3.  Risk prediction models for esophageal cancer: A systematic review and critical appraisal.

Authors:  He Li; Dianqin Sun; Maomao Cao; Siyi He; Yadi Zheng; Xinyang Yu; Zheng Wu; Lin Lei; Ji Peng; Jiang Li; Ni Li; Wanqing Chen
Journal:  Cancer Med       Date:  2021-08-20       Impact factor: 4.452

4.  Risk Prediction Model for Esophageal Cancer Among General Population: A Systematic Review.

Authors:  Ru Chen; Rongshou Zheng; Jiachen Zhou; Minjuan Li; Dantong Shao; Xinqing Li; Shengfeng Wang; Wenqiang Wei
Journal:  Front Public Health       Date:  2021-12-01

5.  A Study on Risk Factors Associated with Reflux Esophagitis in Patients Undergoing Esophageal Cancer Surgery.

Authors:  Ping Wang; Chunzhi Liu; Lianmin Wei; Wenchao Wei; Zhao Liu; Fengting Wu; Rui Qu
Journal:  J Healthc Eng       Date:  2022-03-27       Impact factor: 2.682

6.  Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.

Authors:  Mengfei Liu; Ren Zhou; Zhen Liu; Chuanhai Guo; Ruiping Xu; Fuyou Zhou; Anxiang Liu; Haijun Yang; Fenglei Li; Liping Duan; Lin Shen; Qi Wu; Hongchen Zheng; Hongrui Tian; Fangfang Liu; Ying Liu; Yaqi Pan; Huanyu Chen; Zhe Hu; Hong Cai; Zhonghu He; Yang Ke
Journal:  EClinicalMedicine       Date:  2022-04-16

7.  Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma.

Authors:  Kai Xiong; Ziyou Tao; Zeyang Zhang; Jianyao Wang; Peng Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-13

8.  CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.

Authors:  Qianqian Ju; Maorong Jiang; Wenxin Huang; Qingbo Yang; Zhenghong Luo; Hui Shi
Journal:  Oncol Rep       Date:  2021-12-08       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.